Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 35.67
-0.31 (-0.86%)
At close: Dec 10, 2025
Ansell Market Cap
Ansell has a market cap or net worth of 5.13 billion as of December 9, 2025. Its market cap has increased by 7.61% in one year.
Market Cap
5.13B
Enterprise Value
6.03B
Revenue
3.06B
Ranking
n/a
PE Ratio
33.94
Stock Price
35.67
Market Cap Chart
Since January 16, 1992, Ansell's market cap has increased from 5.00B to 5.13B, an increase of 2.71%. That is a compound annual growth rate of 0.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 5.13B | 4.87% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | 4.47B | 18.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.88B |
| Pro Medicus | 26.02B |
| Cochlear | 17.62B |
| Sonic Healthcare | 11.42B |
| Ramsay Health Care | 8.33B |
| Telix Pharmaceuticals | 5.02B |
| Mesoblast | 3.41B |
| Neuren Pharmaceuticals | 2.50B |